Found 4 results
Name | Type of Offering | Accepted Date |
---|---|---|
Taysha Gene Therapies, Inc.
|
D | 2023-08-25 16:29:35 |
Amount To Be Raised
$149,997,018
Associated Brokers / Dealers
N/A
CIK Number
0001806310
Filed Document
0001231919-23-000063
Exclusions or Exemptions
506b
Accepted Date
2023-08-25 16:29:35
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Taysha Gene Therapies, Inc.
|
D | 2022-11-07 08:45:45 |
Amount To Be Raised
$30,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001806310
Filed Document
0001806310-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-11-07 08:45:45
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Taysha Gene Therapies, Inc.
|
D | 2020-05-01 19:07:12 |
Amount To Be Raised
$30,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001806310
Filed Document
0001806310-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-05-01 19:07:12
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Taysha Gene Therapies, Inc.
|
D | 2020-08-18 16:09:04 |
Amount To Be Raised
$95,999,816
Associated Brokers / Dealers
N/A
CIK Number
0001806310
Filed Document
0001806310-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-08-18 16:09:04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|